The encyclopedia · Advertising & PR · Marketing decision · 2026
Kind Patches sold a 'GLP-1 patch' to breastfeeding mothers as if it were the jab
A Facebook ad pitched the patch as the smarter path past 'those sharp things once a week'. ASA: a medicinal claim for an unlicensed product, irresponsibly.
Kind Patches · 2026-07-15
What happened
In March 2026 a paid Facebook ad for Kind Patches' 'GLP-1 Patch' ran in the UK: 'Take control of your cravings and metabolism with the GLP-1 Patch — your smarter path to weight management. Reduce hunger naturally. Stay fuller for longer.' The video showed a woman applying the patch, with on-screen text aimed at 'a breastfeeding mom who wants to be snatched but can't use those sharp things once a week'.
The ASA upheld both challenges. First: read together with 'GLP-1 Patch', the hunger and cravings claims meant the product was presented as equivalent to GLP-1 agonist injections — prescription-only medicines. An unlicensed product making a medicinal claim. Second: the ad was irresponsible — it promoted the patch to breastfeeding mothers despite Kind Patches' own advice to consult a healthcare professional first, and it exploited postpartum body-image insecurities.
The ad had been created by an affiliate: Kind Patches said it never briefed or approved the post, but accepted responsibility under the CAP Code. The ruling of 15 July 2026 barred the ad in the same form; Kind Patches removed the post and introduced senior sign-off for content reaching vulnerable audiences.
Why it happened
- 'GLP-1 Patch' plus 'reduce hunger naturally' read as equivalence to prescription injections — a medicinal claim an unlicensed product cannot make.
- The ad targeted breastfeeding mothers with 'wants to be snatched', exploiting body-image insecurity and bypassing the company's own medical advice.
- The affiliate defence failed: Kind Patches did not approve the post, but under the CAP Code it still owned it.
The lesson
Riding a drug's fame doesn't lend you its claims: Kind Patches' 'GLP-1 patch' was ruled a medicinal claim for an unlicensed product — and affiliate posts count as yours.
Aftermath
The ASA ruling of 15 July 2026 upheld both challenges: no medicinal claims for unauthorised products, no irresponsible targeting. Kind Patches removed the ad, reviewed its affiliate sign-off process and added senior approval for content reaching vulnerable audiences.
Sources
spotted an error? The club wants to know.
More like this
Airbrush's fake magazine endorsements banned — logos, clips and reviews all invented
Beauty Pie's LED mask poster said 'clinically proven' — the study didn't prove it
Rimmel's 'slay this back to school season' concealer ad banned
Somewhere, someone solved the problem this company failed at. 2nd Opinion →
Comments · 0
Sign in to join the comments.